bRapid real-time PCR (RT-PCR) can be performed in a community hospital setting to identify Coccidioides species using the new Becton Dickinson molecular instrument BD Max. Following sample preparation, DNA extraction and PCR were performed on the BD Max using the BD Max extraction kit ExK-DNA-1 test strip and a master mix prepared by BioGX (Birmingham, AL). Sample preparation took 2 h, and testing on the BD Max took an additional 2 h. Method sensitivity and specificity were evaluated along with the limits of detection to confirm that this convenient method would provide medically useful information. Using serial dilutions, the lower limit of detection was determined to be 1 CFU/l. Testing with this method was validated using samples from various body sites, including bronchial alveolar lavage (BAL) fluid; sputum and lung tissue samples; and pleural and spinal fluids. Safety protocols were established, and specimen preparation processes were developed for the various types of specimens. The range for the cycle threshold (C T ) indicating adequate fluorescent signal to signify a positive result was established along with the acceptable range for the internal standard. Positive controls run with each batch were prepared by spiking a pooled BAL fluid specimen with a known dilution of Coccidioides immitis organism. Our experience with testing >330 patient samples shows that clinically relevant information can be available within 4 h using an RT-PCR method on the BD Max to identify Coccidioides spp., with sensitivity equivalent to culture.
V alley fever caused by the dimorphic fungi Coccidioides immitis in the Central Valley of California and Coccidioides posadasiiin other arid areas of the southwestern United States continues to be an important illness in those areas (1-3). According to the Centers for Disease Control and Prevention, 4,431 cases of Valley fever were reported in California in 2012 (4). For most healthy residents of the Central Valley who contract this infection, Valley fever causes a rather mild influenza-like illness. However, the illness can be severe in some individuals, especially those with a compromised immune system. Without sensitive testing methods, it is usually not possible to distinguish the early symptoms of coccidioidomycosis from other causes of community-acquired pneumonia, which may lead to delayed or improper treatment (5).Current laboratory testing methods rely on lengthy, labor-intensive protocols using experienced and highly skilled laboratory personnel. Methods include traditional serology testing for immunodiffusion tube precipitin (TP) or complement fixation (CF) antibody, enzyme immunoassays, culture, and histopathology (6). Serology testing for Coccidioides is helpful but has limitations for diagnosing current, active infections, since antibodies may be slow to increase to detectable levels, especially in immunocompromised patients (7, 8). Culture-based methods require several days or weeks to grow sufficient fungi for identification by molecular methods, posing additional sa...